24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Cukierman
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:06
Who pays when an AI agent tries again?
13:00
Brandlight helps enterprise marketers manage how AI recommends their brand
12:00
BlueGreen Water Technologies turns algae blooms into large-scale carbon removal
11:21
Taboola to acquire Dianomi for up to £27 million as it pushes deeper into finance advertising
More stories
Buzz
Most popular
Daily
Weekly
1
Serbia opens Israeli drone factory as defense ties with Elbit deepen
2
The man who helped build Palo Alto’s Cortex is leaving the company
3
“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B
4
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
5
Sayeret Matkal veterans raise $22 million to teach the world English with AI
More news
Cukierman
3 stories about Cukierman
Prepare for a year of M&As in Israeli life sciences companies
28.11.21
|
Laurent Choppe
Massive fund raising, significant growth in M&A deals and even a first Israeli biomed SPAC; Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences, explains the current trends behind the sector's amazing year and discusses what’s next
Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert
17.07.20
|
Allon Sinai
"We don't talk anymore about devices or drugs. We talk about healthtech convergence, which for me is the future," explains Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences
U.S.-China Trade War an Opportunity for Israeli Tech, Says Venture Capitalist
31.10.19
|
Lilach Baumer
Edouard Cukierman of Cukierman & Co. and Catalyst sees potential in the mounting trade tensions between the U.S. and China, and thinks Israeli companies should steer clear of Chinese politics